Labeled Astemizole. Nonsedating-type histamine H1-receptor antagonist. Potential for combination therapy with antivancer drugs such as doxorubicin in resistant leukemia. Antihistaminic. Solubility: As Reported Melting Point: As reported Method for Determining Identity: Proton NMR (CDCl3), 19F NMR (CDCl3) Spectroscopic and Mass Spectrometric Analysis TLC Conditions: As Reported Normalized Intensity: As reported Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at 4C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
Molecular Weight:
461.59
Purity:
Chemical: ~90% Isotopic: ~90%
CAS Number:
[1189961-39-4]
* VAT and and shipping costs not included. Errors and price changes excepted
